Literature DB >> 2776793

A measurement of regional portal blood flow with Xe-133 and balloon catheter in man.

Y Yasuhara1, S Miyauchi, K Hamamoto.   

Abstract

This investigation was undertaken to measure regional portal blood flow of the liver. The measurement was performed by injecting 133Xe into the proper hepatic artery through a balloon catheter and then occluding the proper hepatic artery with an inflated balloon. Data were collected using a gamma camera, and washout curves were generated. They were analyzed by the initial slope method and Kety Schmidt equation. The average regional portal blood flows were: 59.31 +/- 13.04 ml/100 g per min, 58.71 +/- 14.14 ml/100 g per min and 37.12 +/- 10.11 ml/100 g per min in hospital controls (11), patients with chronic hepatitis (10) and those with liver cirrhosis (56), respectively. In the patients with cirrhosis, the regional portal blood flow was significantly reduced (P less than 0.01). The reproducibility of this method was satisfactory. The measurement of regional portal blood flow will be useful to evaluate underlying liver injuries and determine indications of a transcatheter arterial embolization of the liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776793     DOI: 10.1007/BF00449222

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  18 in total

1.  Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals.

Authors:  W G SCHENK; J C McDONALD; K McDONALD; T DRAPANAS
Journal:  Ann Surg       Date:  1962-09       Impact factor: 12.969

2.  Disturbances in hepatic blood flow during anesthesia and surgery.

Authors:  S I Gelman
Journal:  Arch Surg       Date:  1976-08

3.  Solubility coefficients of 85 Krypton and 133 Xenon in water, saline, lipids, and blood.

Authors:  K Kitani
Journal:  Scand J Clin Lab Invest       Date:  1972-04       Impact factor: 1.713

4.  In vitro determination of solubility of 133 Xenon and 85 Krypton in human liver tissue with varying triglyceride content.

Authors:  K Kitani; K Winkler
Journal:  Scand J Clin Lab Invest       Date:  1972-04       Impact factor: 1.713

5.  Liver blood flow in man during abdominal surgery. 1. Description of a method utilizing intrahepatic injections of radioactive xenon (133Xe). Normal values and effect of temporary occulsion.

Authors:  L E Gelin; D H Lewis; L Nilsson
Journal:  Acta Hepatosplenol       Date:  1968 Jan-Feb

Review 6.  Hepatic vascular bed.

Authors:  C V Greenway; R D Stark
Journal:  Physiol Rev       Date:  1971-01       Impact factor: 37.312

7.  Determination of the hepatic blood flow in man by simultaneous use of five test substances measured in two parts of the liver.

Authors:  K Winkler; J A Larsen; T Munkner; N Tygstrup
Journal:  Scand J Clin Lab Invest       Date:  1965       Impact factor: 1.713

8.  Determination of liver and spleen perfusion by quantitative sequential scintigraphy: results in normal subjects and in patients with portal hypertension.

Authors:  H J Biersack; J Torres; M Thelen; O Monzon; C Winkler
Journal:  Clin Nucl Med       Date:  1981-05       Impact factor: 7.794

9.  Partition coefficient of 133-xenon between various tissues and blood in vivo.

Authors:  A M Andersen; J Ladefoged
Journal:  Scand J Clin Lab Invest       Date:  1967       Impact factor: 1.713

10.  Measurement of regional hepatic blood flow by scintiphotosplenoportography.

Authors:  T Kashiwagi; K Kimura; T Kamada; H Abe
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1978-08
View more
  2 in total

1.  Clinical significance of the measurement of hepatic blood flow using xenon 133 and balloon catheter in patients undergoing treatment for hepatocellular carcinoma.

Authors:  S Miyauchi; Y Yasuhara; Y Ohta
Journal:  Eur J Nucl Med       Date:  1991

2.  Difference in regional hepatic blood flow in liver segments--non-invasive measurement of regional hepatic arterial and portal blood flow in human by positron emission tomography with H2(15)O.

Authors:  H Taniguchi; A Oguro; K Takeuchi; K Miyata; T Takahashi; T Inaba; H Nakahashi
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.